Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Upadacitinib effectively treats psoriasis and lichen planus together.

UV light helped human hair transplants survive in mice without broad immunosuppression.

JAK inhibitors may help improve symptoms in adults with APECED.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Upadacitinib may effectively treat alopecia areata without side effects.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Electrochemotherapy successfully treated skin tumors in cats without recurrence.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Tazarotene gel may be more effective for acne than adapalene gel.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.